Companies

Pulmonx Corp

LUNG · CIK 0001127537 · operating

$1.52-3.79%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$62.90M
P/E
Fwd P/E-1.14
PEG
P/S0.69
P/B1.05
EV/EBITDA-0.77
EV/Rev0.47

Profitability

Gross Margin74.00%
Op. Margin-68.87%
Net Margin-67.30%
ROE-65.72%
ROA-34.63%
FCF Margin-39.37%

Financial Health

Current Ratio5.58
Debt/Equity0.90
Free Cash Flow-$32.98M
Div. Yield

Growth & Other

Revenue Growth22.01%
EPS Growth10.00%
Beta0.12
52W High$8.72
52W Low$1.31

About Pulmonx Corp

Pulmonx Corp (LUNG) is a surgical & medical instruments & apparatus company incorporated in DE, listed on the Nasdaq. With a market capitalization of $67 million, Pulmonx Corp is a micro-cap company. The stock currently trades at $1.52, down 3.79% today, with a 52-week range of $1.31–$9.32.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-1.44$-1.44+10.0%
2023$-1.60$-1.60-0.6%
2022$-1.59$-1.59-17.8%
2021$-1.35$-1.35
2020

Annual Reports (10-K) · 5 filings

Report DateFiledAccession Number
2024-12-312025-02-250001127537-25-000012SEC ↗
2023-12-312024-02-270001127537-24-000024SEC ↗
2022-12-312023-03-010001127537-23-000011SEC ↗
2021-12-312022-03-010001127537-22-000013SEC ↗
2020-12-312021-03-150001127537-21-000008SEC ↗